Pub Date : 2021-08-12DOI: 10.15406/jcpcr.2021.12.00465
R. Vasanwala, Joseph R. Malhis, Vivek Malhotra, Ethan Anderson, Kerry J Williams-Wuch
The glucagon secreted by a glucagonoma causes the combination of symptoms known as glucagonoma syndrome. 1 A common presenting feature of glucagonoma syndrome is necrolytic migratory erythema (NME) occurring in about 70 to 80 percent of patients. 2,3 Although this rash is can be found in a handful of other disorders, NME should raise an alarm for glucagonoma syndrome especially if present with systemic symptoms. We present a 51 year old male with a past medical history of type 2 diabetes who presented to oncology after seeing several dermatologists regarding a progressive painful pruritic papular rash along his lower extremities and groin. Previous punch biopsies did not reveal the characteristic findings of necrolytic migratory erythema and the rash was thought to be pustular psoriasis. It was only after over a year as the patient continued to worsen that a malignancy work up was done. Eventually glucagonoma syndrome was confirmed. Necrolytic migratory erythema can disguise itself as several different types of rashes. An unusual or unresponsive psoriasiform rash should prompt an investigation for an alternative diagnosis.
{"title":"Identifying necrolytic migratory erythema in glucagonoma syndrome ","authors":"R. Vasanwala, Joseph R. Malhis, Vivek Malhotra, Ethan Anderson, Kerry J Williams-Wuch","doi":"10.15406/jcpcr.2021.12.00465","DOIUrl":"https://doi.org/10.15406/jcpcr.2021.12.00465","url":null,"abstract":"The glucagon secreted by a glucagonoma causes the combination of symptoms known as glucagonoma syndrome. 1 A common presenting feature of glucagonoma syndrome is necrolytic migratory erythema (NME) occurring in about 70 to 80 percent of patients. 2,3 Although this rash is can be found in a handful of other disorders, NME should raise an alarm for glucagonoma syndrome especially if present with systemic symptoms. We present a 51 year old male with a past medical history of type 2 diabetes who presented to oncology after seeing several dermatologists regarding a progressive painful pruritic papular rash along his lower extremities and groin. Previous punch biopsies did not reveal the characteristic findings of necrolytic migratory erythema and the rash was thought to be pustular psoriasis. It was only after over a year as the patient continued to worsen that a malignancy work up was done. Eventually glucagonoma syndrome was confirmed. Necrolytic migratory erythema can disguise itself as several different types of rashes. An unusual or unresponsive psoriasiform rash should prompt an investigation for an alternative diagnosis.","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"117 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74527307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-07-29DOI: 10.15406/jcpcr.2021.12.00464
Tamara Marques Previ, Andre Fellipe Freitas Rodrigues
The irrational use of drugs today is relevant, so pharmacoeconomics is an analytical tool that links economic factors related to drug use and clinical outcomes. Biological medicines are products derived from genetically modified living cell sources. In this context, the biosimilar drug presents similarity in structure, function, efficacy and safety when compared to the original product. Currently several biosimilars are being developed for the treatment of breast cancer, a fact that directly impacts patient survival. Breast cancer is one of the most common types of cancer, being HER2 positive one of the most aggressive forms of the disease, and its treatment is based on the use of cytotoxic drugs associated with targeted therapy using the monoclonal antibody transtuzumab. There are positive future prospects related to biosimilars with impacts on survival and potential increase of patients with access to innovative treatments. The research aimed to analyze the financial impact of the use of the biosimilar trastuzumab and the increase in the number of patients with access to therapies, through a retrospective documentary cross-sectional study, developed on a representative sample of cost values of the drugs Herceptin and Zedora, for the reference protocol trastuzumab. The results obtained in the descriptive statistics through the analysis of variance were not significant; however, a percentage of savings of 27.89% was obtained for the biosimilar Zedora when compared to Herceptin. Monoclonal antibodies are responsible for 35% of the expenses in oncology. The introduction of biosimilars can contribute to the financial and budgetary sustainability of the health system. Based on the results obtained, it is possible to affirm that for every three patients treated with Herceptin, it is possible to treat four patients using Zedora.
{"title":"Relationship between innovative and biosimilar trastuzumab used in the treatment of breast cancer: cross-sectional study of financial impact","authors":"Tamara Marques Previ, Andre Fellipe Freitas Rodrigues","doi":"10.15406/jcpcr.2021.12.00464","DOIUrl":"https://doi.org/10.15406/jcpcr.2021.12.00464","url":null,"abstract":"The irrational use of drugs today is relevant, so pharmacoeconomics is an analytical tool that links economic factors related to drug use and clinical outcomes. Biological medicines are products derived from genetically modified living cell sources. In this context, the biosimilar drug presents similarity in structure, function, efficacy and safety when compared to the original product. Currently several biosimilars are being developed for the treatment of breast cancer, a fact that directly impacts patient survival. Breast cancer is one of the most common types of cancer, being HER2 positive one of the most aggressive forms of the disease, and its treatment is based on the use of cytotoxic drugs associated with targeted therapy using the monoclonal antibody transtuzumab. There are positive future prospects related to biosimilars with impacts on survival and potential increase of patients with access to innovative treatments. The research aimed to analyze the financial impact of the use of the biosimilar trastuzumab and the increase in the number of patients with access to therapies, through a retrospective documentary cross-sectional study, developed on a representative sample of cost values of the drugs Herceptin and Zedora, for the reference protocol trastuzumab. The results obtained in the descriptive statistics through the analysis of variance were not significant; however, a percentage of savings of 27.89% was obtained for the biosimilar Zedora when compared to Herceptin. Monoclonal antibodies are responsible for 35% of the expenses in oncology. The introduction of biosimilars can contribute to the financial and budgetary sustainability of the health system. Based on the results obtained, it is possible to affirm that for every three patients treated with Herceptin, it is possible to treat four patients using Zedora.","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75323722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-07-19DOI: 10.15406/jcpcr.2021.12.00463
H. Antunes, L. D. B. Alves, Ana C S Menezes, A. Costa, F. Heimlich, D. Goldemberg
Aim: To present the dental procedures necessary for the prevention, diagnosis, and treatment of oral toxicities related to cancer treatment. Material and methods: A narrative literature review was carried out regarding the topics of interest. Articles in Portuguese and English, without the restriction of the year of publication and full text available in the databases Pubmed, Scielo, Cochrane, and Google Scholar were investigated. Results: Through this search, 100 articles were selected, consisting of 9 systematic reviews, 3 systematic reviews with meta-analysis, 48 literature reviews, 3 randomized clinical trials, 4 prospective cohorts, 12 retrospective cohorts, 5 cross-sectional studies, 2 case-control studies, 5 case reports, 7 expert consensus panels, 1 letter to the editor and 1 qualitative study, published between 1976 and 2020. Dental procedures were classified according to the therapeutic modality (surgery and radiotherapy for head and neck cancer, chemotherapy, hematopoietic stem cell transplantation, and use of antiresorptive medications) and the time of treatment (prior, during, or after each one). Conclusions: The consulted articles were unanimous regarding the need for dental care for cancer patients in the pre, trans, and post-treatment, highlighting the importance of inserting specialized dental surgeons in the oncology patient care team; thus, this professional should act in the prevention, early diagnosis, and treatment of oral toxicities, to minimize their consequences and improve patients’ quality of life.
{"title":"Strategies for the dentist management of cancer patients: narrative literature review ","authors":"H. Antunes, L. D. B. Alves, Ana C S Menezes, A. Costa, F. Heimlich, D. Goldemberg","doi":"10.15406/jcpcr.2021.12.00463","DOIUrl":"https://doi.org/10.15406/jcpcr.2021.12.00463","url":null,"abstract":"Aim: To present the dental procedures necessary for the prevention, diagnosis, and treatment of oral toxicities related to cancer treatment. Material and methods: A narrative literature review was carried out regarding the topics of interest. Articles in Portuguese and English, without the restriction of the year of publication and full text available in the databases Pubmed, Scielo, Cochrane, and Google Scholar were investigated. Results: Through this search, 100 articles were selected, consisting of 9 systematic reviews, 3 systematic reviews with meta-analysis, 48 literature reviews, 3 randomized clinical trials, 4 prospective cohorts, 12 retrospective cohorts, 5 cross-sectional studies, 2 case-control studies, 5 case reports, 7 expert consensus panels, 1 letter to the editor and 1 qualitative study, published between 1976 and 2020. Dental procedures were classified according to the therapeutic modality (surgery and radiotherapy for head and neck cancer, chemotherapy, hematopoietic stem cell transplantation, and use of antiresorptive medications) and the time of treatment (prior, during, or after each one). Conclusions: The consulted articles were unanimous regarding the need for dental care for cancer patients in the pre, trans, and post-treatment, highlighting the importance of inserting specialized dental surgeons in the oncology patient care team; thus, this professional should act in the prevention, early diagnosis, and treatment of oral toxicities, to minimize their consequences and improve patients’ quality of life.","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"22 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77847721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Epithelioid sarcoma (ES) is a rare high-grade sarcoma subtype that constitutes less than 1% of soft tissue sarcomas (STS).There are two types: distal-type epithelioid sarcoma and proximal-type epithelioid sarcoma, based on anatomic location and the histopathological features. The clinical presentation of ES is varied and can lead to a delay in diagnosis. histopathology examination followed by immunohistochemistry will help to establish the diagnosis. The treatment of choice of Localized ES is a radical excision with microscopically radical margins and perioperative radiotherapy. systemic therapies are used in cases of locally advanced or metastatic ES. We describe a case of reoccurring proximal-type epithelioid sarcoma of the ischioanal fossa. A 56-year-old man operated two years ago for a epithelioid sarcoma of the ischioanal fossa. The patient presented with reoccurring mass at the same location, Magnetic resonance imaging (MRI) of the pelvis showed a mass of the ischioanal fossa. computed tomography (CT) of the chest, abdomen, and pelvis showed multiple pulmonary and liver metastasis. Histopathological features and immunohistochemistry were those of proximal type epithelioid sarcoma. He received intravenous doxorubicin with a partial response after 3 cycles of treatment.
{"title":"A rare case of metastatic proximal-type epithelioid sarcoma of the ischioanal fossa: case report and literature review","authors":"Harrak Soukaina, Lemsanes Siham, Razine Sawsan, Benchekroun Khadija, Lkhouyaali Siham, Abahsaine Halima, Boutayeb Saber, Errihani Hassan","doi":"10.15406/JCPCR.2021.12.00462","DOIUrl":"https://doi.org/10.15406/JCPCR.2021.12.00462","url":null,"abstract":"Epithelioid sarcoma (ES) is a rare high-grade sarcoma subtype that constitutes less than 1% of soft tissue sarcomas (STS).There are two types: distal-type epithelioid sarcoma and proximal-type epithelioid sarcoma, based on anatomic location and the histopathological features. The clinical presentation of ES is varied and can lead to a delay in diagnosis. histopathology examination followed by immunohistochemistry will help to establish the diagnosis. The treatment of choice of Localized ES is a radical excision with microscopically radical margins and perioperative radiotherapy. systemic therapies are used in cases of locally advanced or metastatic ES. We describe a case of reoccurring proximal-type epithelioid sarcoma of the ischioanal fossa. A 56-year-old man operated two years ago for a epithelioid sarcoma of the ischioanal fossa. The patient presented with reoccurring mass at the same location, Magnetic resonance imaging (MRI) of the pelvis showed a mass of the ischioanal fossa. computed tomography (CT) of the chest, abdomen, and pelvis showed multiple pulmonary and liver metastasis. Histopathological features and immunohistochemistry were those of proximal type epithelioid sarcoma. He received intravenous doxorubicin with a partial response after 3 cycles of treatment.","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"74 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72907051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-06-15DOI: 10.15406/jcpcr.2021.12.00460
F. Kulalı
{"title":"Biliary mucinous cystic neoplasm with invasive carcinoma and recurrent cholangitis due to hepatolithiasis","authors":"F. Kulalı","doi":"10.15406/jcpcr.2021.12.00460","DOIUrl":"https://doi.org/10.15406/jcpcr.2021.12.00460","url":null,"abstract":"","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"92 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77353234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-05-12DOI: 10.15406/JCPCR.2021.12.00458
Joseph R. Malhis, Chintav Shah, S. O’Brien, R. Vasanwala, S. Jaggernauth
{"title":"Three-in-one: case of multiple primary malignancies concurrently in a 70 year-old female","authors":"Joseph R. Malhis, Chintav Shah, S. O’Brien, R. Vasanwala, S. Jaggernauth","doi":"10.15406/JCPCR.2021.12.00458","DOIUrl":"https://doi.org/10.15406/JCPCR.2021.12.00458","url":null,"abstract":"","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"23 1","pages":"78-80"},"PeriodicalIF":0.0,"publicationDate":"2021-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73572867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-05-11DOI: 10.15406/JCPCR.2021.12.00457
Joseph R. Malhis, S. O’Brien, Alex Belote, B. Brander
A 64-year-old male presents with acute encephalopathy and upon further evaluation, he was found to have lymphadenopathy in the neck and parotid region. Subsequent lumbar puncture (LP) revealed the presence of blast cells in the CSF concerning for leukemic meningitis. A lymph node biopsy was consistent with CD5 positive DLBCL. He was started on chemotherapy with Hyper-CVAD and intrathecal methotrexate, improving his clinical condition but he was lost to follow up. Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL). Diagnosis is based on symptoms and excisional lymph node biopsy with immunotyping. It is extremely important to have a lymph node biopsy if suspicious for lymphoma because of its aggressive nature. Indicators for such include CD5 positivity and extranodal involvement. The risk factors for CNS involvement in DLBCL include high International Prognostic Index (IPI) score, bone marrow involvement, and extranodal involvement such as bone, lung and testis. The purpose of the report is to emphasize the importance of ruling out lymphoma when diffuse lymphadenopathy is present in the setting of encephalopathy; the potential of aggressive behavior of this disease including involvement of the CNS; and discussing the overall social determinants of health for this patient resulting in delayed diagnosis and lack of an optimal treatment plan to be carried out.
{"title":"Curious case of acute encephalopathy in a 64-yearold male","authors":"Joseph R. Malhis, S. O’Brien, Alex Belote, B. Brander","doi":"10.15406/JCPCR.2021.12.00457","DOIUrl":"https://doi.org/10.15406/JCPCR.2021.12.00457","url":null,"abstract":"A 64-year-old male presents with acute encephalopathy and upon further evaluation, he was found to have lymphadenopathy in the neck and parotid region. Subsequent lumbar puncture (LP) revealed the presence of blast cells in the CSF concerning for leukemic meningitis. A lymph node biopsy was consistent with CD5 positive DLBCL. He was started on chemotherapy with Hyper-CVAD and intrathecal methotrexate, improving his clinical condition but he was lost to follow up. Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL). Diagnosis is based on symptoms and excisional lymph node biopsy with immunotyping. It is extremely important to have a lymph node biopsy if suspicious for lymphoma because of its aggressive nature. Indicators for such include CD5 positivity and extranodal involvement. The risk factors for CNS involvement in DLBCL include high International Prognostic Index (IPI) score, bone marrow involvement, and extranodal involvement such as bone, lung and testis. The purpose of the report is to emphasize the importance of ruling out lymphoma when diffuse lymphadenopathy is present in the setting of encephalopathy; the potential of aggressive behavior of this disease including involvement of the CNS; and discussing the overall social determinants of health for this patient resulting in delayed diagnosis and lack of an optimal treatment plan to be carried out.","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"43 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76853670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-04-23DOI: 10.15406/JCPCR.2021.12.00454
Aditi Agrawal, Rajshri Kelkar, Tuhina Mishra
Breast cancer is the commonest malignancy in the world Unilateral serous or serosanguinous nipple discharge is always a cause for concern. 10% of the cases are due to malignant causes. However, we report a rare case of a 52 year old woman with serosanguinous nipple discharge who was later diagnosed with unilateral breast carcinoma with three different histological types which were not detected by mammogram and a MRI Breast was needed to diagnose it. It is a rarity and not reported till date.
{"title":"Unilateral breast carcinoma with three different histological types-case report","authors":"Aditi Agrawal, Rajshri Kelkar, Tuhina Mishra","doi":"10.15406/JCPCR.2021.12.00454","DOIUrl":"https://doi.org/10.15406/JCPCR.2021.12.00454","url":null,"abstract":"Breast cancer is the commonest malignancy in the world Unilateral serous or serosanguinous nipple discharge is always a cause for concern. 10% of the cases are due to malignant causes. However, we report a rare case of a 52 year old woman with serosanguinous nipple discharge who was later diagnosed with unilateral breast carcinoma with three different histological types which were not detected by mammogram and a MRI Breast was needed to diagnose it. It is a rarity and not reported till date.","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"565 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75929112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-04-21DOI: 10.15406/JCPCR.2021.12.00453
Adrianne Moura Carvalho, G. Salerno
Cancer is characterized by disorganized and chaotic cell growth that results from genetic changes inherited or acquired by the action of certain environmental, chemical, radioactive, viral and hormonal agents named carcinogens, which thereby initiate the process of tumorigenesis.1 Breast cancer is the second most common form of cancer in the world and the leading cause of death by cancer among females. It mainly affects women aged between 40 and 60 years.1,2 The main risk factors are genetics and external, such as environment, living habits, eating habits, age, menarche, exposure to estrogen, radiation, obesity, sedentarism and environmental toxins.1,2
{"title":"Physiotherapeutic performance in mastectomy after breast cancer: a literature review","authors":"Adrianne Moura Carvalho, G. Salerno","doi":"10.15406/JCPCR.2021.12.00453","DOIUrl":"https://doi.org/10.15406/JCPCR.2021.12.00453","url":null,"abstract":"Cancer is characterized by disorganized and chaotic cell growth that results from genetic changes inherited or acquired by the action of certain environmental, chemical, radioactive, viral and hormonal agents named carcinogens, which thereby initiate the process of tumorigenesis.1 Breast cancer is the second most common form of cancer in the world and the leading cause of death by cancer among females. It mainly affects women aged between 40 and 60 years.1,2 The main risk factors are genetics and external, such as environment, living habits, eating habits, age, menarche, exposure to estrogen, radiation, obesity, sedentarism and environmental toxins.1,2","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"13 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77647148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-03-23DOI: 10.15406/JCPCR.2021.12.00451
J. Prasad, Pradyuman Verma, N. Tyagi
Severe Acute Respiratory Syndrome Corona virus 2 (SARS– CoV–2) is named as Corona-virus that causes Corona virus disease 2019 (COVID-19). Corona virus disease is transmitted from people to people through respiratory droplets and contact routes.1 Droplet transmission occurs through close contacts with someone who has COVID-19 symptoms. Hence, Corona virus disease transmission occurs by direct contact with infected people or by contacts with surfaces in the immediate environment or objects, used by infected persons. Thus, people may acquire Corona virus disease through air or after touching contaminated objects even after hours.2 Airborne transmission of the disease could be possible in specific circumstances and settings. WHO declared outbreak of COVID-19 disease a Public Health Emergency of International Concern on 30 January 2020.3
{"title":"A study on disease dynamics of covid-19 in different states of India: A data driven analysis of the available evidence","authors":"J. Prasad, Pradyuman Verma, N. Tyagi","doi":"10.15406/JCPCR.2021.12.00451","DOIUrl":"https://doi.org/10.15406/JCPCR.2021.12.00451","url":null,"abstract":"Severe Acute Respiratory Syndrome Corona virus 2 (SARS– CoV–2) is named as Corona-virus that causes Corona virus disease 2019 (COVID-19). Corona virus disease is transmitted from people to people through respiratory droplets and contact routes.1 Droplet transmission occurs through close contacts with someone who has COVID-19 symptoms. Hence, Corona virus disease transmission occurs by direct contact with infected people or by contacts with surfaces in the immediate environment or objects, used by infected persons. Thus, people may acquire Corona virus disease through air or after touching contaminated objects even after hours.2 Airborne transmission of the disease could be possible in specific circumstances and settings. WHO declared outbreak of COVID-19 disease a Public Health Emergency of International Concern on 30 January 2020.3","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85371688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：